IL39218A - 2,4-diamino-5-(3,4,5-triethoxybenzyl) pyrimidine its preparation and pharmaceutical compositions containing it - Google Patents

2,4-diamino-5-(3,4,5-triethoxybenzyl) pyrimidine its preparation and pharmaceutical compositions containing it

Info

Publication number
IL39218A
IL39218A IL39218A IL3921872A IL39218A IL 39218 A IL39218 A IL 39218A IL 39218 A IL39218 A IL 39218A IL 3921872 A IL3921872 A IL 3921872A IL 39218 A IL39218 A IL 39218A
Authority
IL
Israel
Prior art keywords
compound
formula
triethoxybenzyl
group
pharmaceutically acceptable
Prior art date
Application number
IL39218A
Other languages
English (en)
Other versions
IL39218A0 (en
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of IL39218A0 publication Critical patent/IL39218A0/xx
Publication of IL39218A publication Critical patent/IL39218A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/41—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by hydrogenolysis or reduction of carboxylic groups or functional derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C07D239/49—Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IL39218A 1971-04-16 1972-04-14 2,4-diamino-5-(3,4,5-triethoxybenzyl) pyrimidine its preparation and pharmaceutical compositions containing it IL39218A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB963971A GB1407971A (en) 1971-04-16 1971-04-16 2,4-diamino -4-3,4,5-triethoxybenzyl pyrimidine and methods of preparation therefor

Publications (2)

Publication Number Publication Date
IL39218A0 IL39218A0 (en) 1972-06-28
IL39218A true IL39218A (en) 1976-10-31

Family

ID=9875880

Family Applications (3)

Application Number Title Priority Date Filing Date
IL39218A IL39218A (en) 1971-04-16 1972-04-14 2,4-diamino-5-(3,4,5-triethoxybenzyl) pyrimidine its preparation and pharmaceutical compositions containing it
IL47921A IL47921A (en) 1971-04-16 1972-04-14 Alpha-(3,4,5-triethoxybenzyl)-acrylonitrile and-propionitrile derivatives and their preparation
IL47921A IL47921A0 (en) 1971-04-16 1975-08-14 New alpha-(3,4,5-triethoxybenzyl)-acrylonitrile and-propionitrile derivatives and their preparation

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL47921A IL47921A (en) 1971-04-16 1972-04-14 Alpha-(3,4,5-triethoxybenzyl)-acrylonitrile and-propionitrile derivatives and their preparation
IL47921A IL47921A0 (en) 1971-04-16 1975-08-14 New alpha-(3,4,5-triethoxybenzyl)-acrylonitrile and-propionitrile derivatives and their preparation

Country Status (13)

Country Link
JP (3) JPS5320511B1 (fr)
AU (1) AU468447B2 (fr)
BE (1) BE782153A (fr)
CA (1) CA967964A (fr)
CH (1) CH565160A5 (fr)
CS (1) CS181221B2 (fr)
DE (1) DE2218220A1 (fr)
DK (1) DK131466B (fr)
FR (1) FR2133752B1 (fr)
GB (1) GB1407971A (fr)
IL (3) IL39218A (fr)
NL (1) NL7205043A (fr)
SE (1) SE391180B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA738760B (en) * 1972-12-21 1974-08-28 Hoffmann La Roche Process for the manufacture of benzyl pyrimidines
GB1469521A (en) * 1973-01-05 1977-04-06 Wellcome Found Antimicrobial preparations
FR2502152A1 (fr) * 1981-03-20 1982-09-24 Panmedica Laboratoires Nouveaux derives solubles n2 substitues de la diamino-2,4-benzyl-5-pyrimidines, leur procede de preparation et medicaments les contenant

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1090394A (fr) * 1953-03-11 1955-03-30 Wellcome Found Dérivés de pyrimidine et leur fabrication
FR1459417A (fr) * 1964-11-12 1966-04-29 Hoffmann La Roche Procédé pour la préparation de dérivés de pyrimidine
FR1518635A (fr) * 1965-07-08 1968-03-29 Wellcome Found Procédé de préparation de dérivés de la pyrimidine
GB1261455A (en) * 1969-03-06 1972-01-26 Burroughs Wellcome Co Improvements in or relating to substituted acrylonitriles

Also Published As

Publication number Publication date
CH565160A5 (fr) 1975-08-15
CS181221B2 (en) 1978-03-31
IL47921A0 (en) 1975-11-25
GB1407971A (en) 1975-10-01
JPS5422994B2 (fr) 1979-08-10
DE2218220A1 (de) 1972-11-02
JPS5320511B1 (fr) 1978-06-27
NL7205043A (fr) 1972-10-18
AU4117472A (en) 1973-10-18
JPS5430189A (en) 1979-03-06
IL47921A (en) 1976-10-31
DK131466B (da) 1975-07-21
JPS53111083A (en) 1978-09-28
DK131466C (fr) 1975-12-08
FR2133752A1 (fr) 1972-12-01
IL39218A0 (en) 1972-06-28
FR2133752B1 (fr) 1975-04-25
BE782153A (fr) 1972-10-16
CA967964A (en) 1975-05-20
AU468447B2 (en) 1976-01-15
SE391180B (sv) 1977-02-07

Similar Documents

Publication Publication Date Title
CA1064496A (fr) Preparation d'un nouveau sel de la vincamine et compose ainsi obtenu
KR920700203A (ko) 피리미딘 유도체
JPH05247039A (ja) 新規テトラオキソ−ジアザビシクロ−（３，３，１）−ノナンおよびその製法
IE37452B1 (en) 2,4-diamino-5-benzylpyrimidines and processes for their production
ES8307760A1 (es) Un procedimiento para la preparacion de derivados de 4-anilino-pirimidina.
GB1261455A (en) Improvements in or relating to substituted acrylonitriles
IL39218A (en) 2,4-diamino-5-(3,4,5-triethoxybenzyl) pyrimidine its preparation and pharmaceutical compositions containing it
JPS6047259B2 (ja) グアニジン化合物の製法
EP0831091A2 (fr) Procédé de préparation de 3-aryl-uraciles
ES454063A1 (es) Un procedimiento para la preparacion de nuevos derivados delalcohol bencilico.
US2675375A (en) Arylazopyrimidine compounds and methods of making the same
GB1469060A (en) Pyrimidinyl-thionophosphonic acid esters process for their preparation and their use as insecticides acaricides and nematocides
GB984471A (en) Anthranilic acid esters and methods for producing the same
US2527494A (en) Process for preparation of orthoformic esters
US20130023661A1 (en) Fluorinating reagents with (perfluoralkyl) fluorophosphate anion
US4335119A (en) Quick-acting diuretic compositions
US3660414A (en) Certain 5-aryl-2-amino-nicotinonitriles
GB583815A (en) New pyrimidine compounds
GB1144039A (en) New naphthyl- and tetrahydronaphthyl-formamidines
JPS63316773A (ja) ４−ニトロ−５−イミダゾリルエーテル及び−チオエーテルの製法
Banerjee et al. Structure of 8-hydroxy-5-quinolinesulphonic acid dihydrate, C9H7NO4S. 2H2O
KR930010498B1 (ko) 리제르골과 10α-메톡시루미리제르골의 N-메틸 유도체 제조방법
JPS5587777A (en) Pyrimidine derivative, its preparation and antitumorigenic agent
IL44341A (en) 6-substituted 3-carbethoxyhydrazinopyridazines their preparation and pharmaceutical compositions containing them
CA1045135A (fr) Pyrrolo (3,4-d) pyrimidines